Product Code: PMRREP33295
Global Preclinical CRO Market: Global Industry Analysis 2018-2022 & Opportunity Assessment 2023-2033
A recent market study published by Persistence Market Research on the global Preclinical CRO market offers global industry analysis for 2018-2022 & opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical, as well as current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Preclinical CRO market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Service Type
Bioanalysis and DMPK studies
In vitro ADME
In-vivo PK
Toxicology Testing
GLP
Non-GLP
Compound Management
Process R&D
Custom Synthesis
Other Compound Managements
Chemistry
Medicinal Chemistry
Computation Chemistry
Safety Pharmacology
Other Service Types
By End-use
Biopharmaceutical Companies
Government and Academic Institutes
Medical Device Companies
On-premises
By Region
North America
Europe
Asia Pacific
Middle East and Africa
Latin America
Report Chapters:
Chapter 01 - Executive Summary
- The executive summary of the global Preclinical CRO market includes the global market analysis, proprietary wheel of fortune, demand-side and supply-side trends, opportunity assessment, and recommendations on the global Preclinical CRO market.
Chapter 02 - Market Overview
- Readers can find the detailed segmentation and definition of the global Preclinical CRO market in this chapter, which will help them understand basic information about the global Preclinical CRO market. This section also highlights the inclusions and exclusions, which help the reader to understand the scope of the global Preclinical CRO market report.
Chapter 03 - Market Background
- The associated industry assessment of the global Preclinical CRO market is carried out in this section. In addition, this chapter explains key macroeconomic factors that are expected to influence the growth of the global Preclinical CRO market over the forecast period. Along with macroeconomic factors, this section also highlights the opportunity analysis for the market. It offers provides key market dynamics of the global Preclinical CRO market, which include drivers, restraints, and opportunities. Moreover, it will help readers understand key trends followed by leading manufacturers in the global Preclinical CRO market.
Chapter 04 - Global Preclinical CRO Market Analysis 2018-2022 and Forecast, 2023-2033
- This section provides detailed analysis of the historical global Preclinical CRO market Value, along with an opportunity analysis of the future. Readers can also find the incremental opportunity for the current year (2022-2023) and an absolute opportunity for the forecast period (2023-2033).
Chapter 05 - Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, by Service Type
- Based on components, the global Preclinical CRO market is segmented into (Software Tools: Bioanalysis and DMPK studies, Toxicology Testing, Compound Management, Chemistry, Safety Pharmacology, Other Service Types). In this chapter, readers can find market attractiveness analysis, based on service type.
Chapter 06 - Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, by End-use
- Based on deployment mode, the global Preclinical CRO market is segmented into Biopharmaceutical Companies, Government and Academic Institutes, Medical Device Companies. In this chapter, readers can find market attractiveness analysis, based on End-use.
Chapter 07 - Global Preclinical CRO Market Analysis 2018-2022 and Opportunity Assessment 2023-2033 by Region
- This chapter explains how the global Preclinical CRO market will grow across various geographic regions, such as North America, Latin America, Europe, Asia Pacific and the Middle East and Africa (MEA).
Chapter 08 - North America Global Preclinical CRO Market market Analysis 2018-2022 & Forecast 2023-2033
- This chapter includes a detailed analysis of the growth of the global Preclinical CRO market in the North America region, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find regional trends, opportunities, and market growth based on components, End use, and countries in the North America region.
Chapter 09 - Latin America Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
- Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the global Preclinical CRO market in the Latin America region. This chapter also includes growth prospects of the global Preclinical CRO market in leading LATAM countries such as Brazil and Mexico.
Chapter 10 - Europe Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
- Important growth prospects of the global Preclinical CRO market based on its product type, price, and sales channel in several countries such as Germany, U.K., France, Italy, BENELUX, Nordics, Russia, and Rest of Europe are included in this chapter.
Chapter 11 - Asia Pacific Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
- This chapter includes a detailed analysis of the growth of the global Preclinical CRO market in the South Asia region, along with a country-wise assessment that includes, China, Japan and South Korea. Readers can also find regional trends, restraints, and market growth of countries in the Asia Pacific region.
Chapter 12 - Middle East and Africa Global Preclinical CRO Market Analysis 2018-2022 & Forecast 2023-2033
- This chapter offers insights into how the global Preclinical CRO market is expected to grow in major countries in the MEA region such as GCC Countries, South Africa, and the Turkey, during the forecast period 2023-2033.
Chapter 13 - Key Countries Preclinical CRO Market Analysis
- This chapter offers insights into how the global Preclinical CRO market is expected to grow in key countries in the such as U.S., Canada, Brazil, Mexico, Germany, U.K., France, Italy, BENELUX, Nordic, Rest of Europe, China, Japan, South Korea, GCC, South Africa, and Turkey during the forecast period 2023-2033.
Chapter 14 - Market Structure Analysis
- In this chapter, readers can find detailed information about tier analysis and market concentration of the key players in the global Preclinical CRO market along with their market presence analysis by region and product portfolio.
Chapter 15 - Competition Deep-Dive Analysis
- In this chapter, readers can find a comprehensive list of manufacturers/ players in the global Preclinical CRO market, along with detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the key players in Preclinical CRO market includes Eurofins Scientific, PRA Health Sciences, Medpace, Pharmaceutical Product Development, ICON Plc, Wuxi Apptec, and MPI Research among others.
Chapter 16 - Assumptions and Acronyms
- This chapter includes a list of acronyms and assumptions that provide a based to the information and statistics included in the global Preclinical CRO market report.
Chapter 17 - Research Methodology
- This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on the global Preclinical CRO market.
Table of Contents
1. Executive Summary
- 1.1. Global Market Outlook
- 1.2. Summary of Statistics
- 1.3. Key Market Characteristics & Attributes
- 1.4. Analysis and Recommendations
2. Market Overview
- 2.1. Market Coverage / Taxonomy
- 2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
- 3.1. Risk Assessment
- 3.2. Key Trends Impacting the Market
- 3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
- 4.1. Global Preclinical CRO Market (US$ Bn)
- 4.2. Preclinical CRO Market Opportunity Assessment (US$ Bn)
- 4.2.1. Total Available Market
- 4.2.2. Serviceable Addressable Market
- 4.2.3. Serviceable Obtainable Market
- 4.3. Market Scenario Forecast
- 4.3.1. Demand in optimistic Scenario
- 4.3.2. Demand in Likely Scenario
- 4.3.3. Demand in Conservative Scenario
- 4.4. Investment Feasibility Analysis
- 4.4.1. Investment in Established Markets
- 4.4.1.1. In Short Term
- 4.4.1.2. In Long Term
- 4.4.2. Investment in Emerging Markets
- 4.4.2.1. In Short Term
- 4.4.2.2. In Long Term
- 4.5. Forecast Factors - Relevance & Impact
- 4.5.1. Top Companies Historical Growth
- 4.5.2. Global Preclinical CRO Market Growth
- 4.5.3. Preclinical CRO Adoption Rate, By Country
- 4.6. Market Dynamics
- 4.6.1. Market Driving Factors and Impact Assessment
- 4.6.2. Prominent Market Challenges and Impact Assessment
- 4.6.3. Preclinical CRO Market Opportunities
- 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
- 5.1. Manufacturers' Focus on Low Penetration High Growth Markets
- 5.2. Banking on with Segments High Incremental Opportunity
- 5.3. Peer Benchmarking
6. Global Preclinical CRO Market Demand Analysis 2018-2022 and Forecast, 2023-2033
- 6.1. Historical Market Analysis, 2018-2022
- 6.2. Current and Future Market Projections, 2023-2033
- 6.3. Y-o-Y Growth Trend Analysis
7. Global Preclinical CRO Market Value Analysis 2018-2022 and Forecast, 2023-2033
- 7.1. Historical Market Value (US$ Bn) Analysis, 2018-2022
- 7.2. Current and Future Market Value (US$ Bn) Projections, 2023-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis
8. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By Service Service Type
- 8.1. Introduction / Key Findings
- 8.2. Historical Market Size (US$ Bn) Analysis By Service Type, 2018-2022
- 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Service Type, 2023-2033
- 8.3.1. Bioanalysis and DMPK studies
- 8.3.1.1. In vitro ADME
- 8.3.1.2. In-vivo PK
- 8.3.2. Toxicology Testing
- 8.3.2.1. GLP
- 8.3.2.2. Non-GLP
- 8.3.3. Compund Management
- 8.3.3.1. Process R&D
- 8.3.3.2. Custom Synthesis
- 8.3.3.3. Other Compound Management
- 8.3.4. Chemistry
- 8.3.4.1. Medicinal Chemistry
- 8.3.4.2. Computation Chemistry
- 8.3.5. Safety Pharmacology
- 8.3.6. Other Service Types
- 8.4. Market Attractiveness Analysis By Service Type
9. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
- 9.1. Introduction / Key Findings
- 9.2. Historical Market Size (US$ Bn) Analysis By End-use, 2018-2022
- 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End-use, 2023-2033
- 9.3.1. Biopharmaceutical Companies
- 9.3.2. Government and Academic Institutes
- 9.3.3. Medical Device Companies
- 9.4. Market Attractiveness Analysis By End-use
10. Global Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033, By Region
- 10.1. Introduction
- 10.2. Historical Market Size (US$ Bn) Analysis By Region, 2018-2022
- 10.3. Current Market Size (US$ Bn) & Analysis and Forecast By Region, 2023-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. APAC
- 10.3.5. Middle East and Africa (MEA)
- 10.4. Market Attractiveness Analysis By Region
11. North America Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
- 11.1. Introduction
- 11.2. Pricing Analysis
- 11.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
- 11.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
- 11.4.1. By Country
- 11.4.1.1. U.S.
- 11.4.1.2. Canada
- 11.4.1.3. Rest of North America
- 11.4.2. By Service Type
- 11.4.3. By End-use
- 11.5. Market Attractiveness Analysis
- 11.5.1. By Country
- 11.5.2. By Service Type
- 11.5.3. By End-use
12. Latin America Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
- 12.1. Introduction
- 12.2. Pricing Analysis
- 12.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
- 12.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
- 12.4.1. By Country
- 12.4.1.1. Brazil
- 12.4.1.2. Mexico
- 12.4.1.3. Rest of Latin America
- 12.4.2. By Service Type
- 12.4.3. By End-use
- 12.5. Market Attractiveness Analysis
- 12.5.1. By Country
- 12.5.2. By Service Type
- 12.5.3. By End-use
13. Europe Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
- 13.1. Introduction
- 13.2. Pricing Analysis
- 13.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
- 13.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
- 13.4.1. By Country
- 13.4.1.1. Germany
- 13.4.1.2. France
- 13.4.1.3. U.K.
- 13.4.1.4. Italy
- 13.4.1.5. Spain
- 13.4.1.6. Netherlands
- 13.4.1.7. Rest of Europe
- 13.4.2. By Service Type
- 13.4.3. By End-use
- 13.5. Market Attractiveness Analysis
- 13.5.1. By Country
- 13.5.2. By Service Type
- 13.5.3. By End-use
14. APAC Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
- 14.1. Introduction
- 14.2. Pricing Analysis
- 14.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
- 14.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
- 14.4.1. By Country
- 14.4.1.1. China
- 14.4.1.2. Japan
- 14.4.1.3. South Korea
- 14.4.1.4. Rest of APAC
- 14.4.2. By Service Type
- 14.4.3. By End-use
- 14.5. Market Attractiveness Analysis
- 14.5.1. By Country
- 14.5.2. By Service Type
- 14.5.3. By End-use
15. Middle East and Africa Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
- 15.1. Introduction
- 15.2. Pricing Analysis
- 15.3. Historical Market Value (US$ Bn) Trend Analysis By Market Taxonomy, 2018-2022
- 15.4. Market Value (US$ Bn) & Forecast By Market Taxonomy, 2023-2033
- 15.4.1. By Country
- 15.4.1.1. Saudi Arabia
- 15.4.1.2. South Africa
- 15.4.1.3. UAE
- 15.4.1.4. Rest of Middle East and Africa
- 15.4.2. By Service Type
- 15.4.3. By End-use
- 15.5. Market Attractiveness Analysis
- 15.5.1. By Country
- 15.5.2. By Service Type
- 15.5.3. By End-use
16. Key Countries Preclinical CRO Market Analysis 2018-2022 and Forecast 2023-2033
- 16.1. Introduction
- 16.1.1. Market Value Proportion Analysis, By Key Countries
- 16.1.2. Global Vs. Country Growth Comparison
- 16.2. US Preclinical CRO Market Analysis
- 16.2.1. Value Proportion Analysis by Market Taxonomy
- 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.2.2.1. By Service Type
- 16.2.2.2. By End-use
- 16.3. Canada Preclinical CRO Market Analysis
- 16.3.1. Value Proportion Analysis by Market Taxonomy
- 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.3.2.1. By Service Type
- 16.3.2.2. By End-use
- 16.4. Mexico Preclinical CRO Market Analysis
- 16.4.1. Value Proportion Analysis by Market Taxonomy
- 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.4.2.1. By Service Type
- 16.4.2.2. By End-use
- 16.5. Brazil Preclinical CRO Market Analysis
- 16.5.1. Value Proportion Analysis by Market Taxonomy
- 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.5.2.1. By Service Type
- 16.5.2.2. By End-use
- 16.6. Germany Preclinical CRO Market Analysis
- 16.6.1. Value Proportion Analysis by Market Taxonomy
- 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.6.2.1. By Service Type
- 16.6.2.2. By End-use
- 16.7. France Preclinical CRO Market Analysis
- 16.7.1. Value Proportion Analysis by Market Taxonomy
- 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.7.2.1. By Service Type
- 16.7.2.2. By End-use
- 16.8. Italy Preclinical CRO Market Analysis
- 16.8.1. Value Proportion Analysis by Market Taxonomy
- 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.8.2.1. By Service Type
- 16.8.2.2. By End-use
- 16.9. Spain Preclinical CRO Market Analysis
- 16.9.1. Value Proportion Analysis by Market Taxonomy
- 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.9.2.1. By Service Type
- 16.9.2.2. By End-use
- 16.10. UK Preclinical CRO Market Analysis
- 16.10.1. Value Proportion Analysis by Market Taxonomy
- 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.10.2.1. By Service Type
- 16.10.2.2. By End-use
- 16.11. Netherlands Preclinical CRO Market Analysis
- 16.11.1. Value Proportion Analysis by Market Taxonomy
- 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.11.2.1. By Service Type
- 16.11.2.2. By End-use
- 16.12. China Preclinical CRO Market Analysis
- 16.12.1. Value Proportion Analysis by Market Taxonomy
- 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.12.2.1. By Service Type
- 16.12.2.2. By End-use
- 16.13. Japan Preclinical CRO Market Analysis
- 16.13.1. Value Proportion Analysis by Market Taxonomy
- 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.13.2.1. By Service Type
- 16.13.2.2. By End-use
- 16.14. South Korea Preclinical CRO Market Analysis
- 16.14.1. Value Proportion Analysis by Market Taxonomy
- 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.14.2.1. By Service Type
- 16.14.2.2. By End-use
- 16.15. Saudi Arabia Preclinical CRO Market Analysis
- 16.15.1. Value Proportion Analysis by Market Taxonomy
- 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.15.2.1. By Service Type
- 16.15.2.2. By End-use
- 16.16. South Africa Preclinical CRO Market Analysis
- 16.16.1. Value Proportion Analysis by Market Taxonomy
- 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.16.2.1. By Service Type
- 16.16.2.2. By End-use
- 16.17. UAE Preclinical CRO Market Analysis
- 16.17.1. Value Proportion Analysis by Market Taxonomy
- 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
- 16.17.2.1. By Service Type
- 16.17.2.2. By End-use
- 16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
- 17.1. Market Analysis by Tier of Companies
- 17.2. Market Concentration
- 17.3. Market Share Analysis of Top Players
- 17.4. Market Presence Analysis
- 17.4.1. By Regional footprint of Players
- 17.4.2. Product footprint by Players
18. Competition Analysis
- 18.1. Competition Dashboard
- 18.2. Competition Benchmarking
- 18.3. Competition Deep Dive
- 18.3.1. Eurofins Scientific
- 18.3.1.1. Overview
- 18.3.1.2. Product Portfolio
- 18.3.1.3. Sales Footprint
- 18.3.1.4. Strategy Overview
- 18.3.2. PRA Health Sciences
- 18.3.2.1. Overview
- 18.3.2.2. Product Portfolio
- 18.3.2.3. Sales Footprint
- 18.3.2.4. Strategy Overview
- 18.3.3. Medpace
- 18.3.3.1. Overview
- 18.3.3.2. Product Portfolio
- 18.3.3.3. Sales Footprint
- 18.3.3.4. Strategy Overview
- 18.3.4. Pharmaceutical Product Development
- 18.3.4.1. Overview
- 18.3.4.2. Product Portfolio
- 18.3.4.3. Sales Footprint
- 18.3.4.4. Strategy Overview
- 18.3.5. Icon Plc
- 18.3.5.1. Overview
- 18.3.5.2. Product Portfolio
- 18.3.5.3. Sales Footprint
- 18.3.5.4. Strategy Overview
- 18.3.6. Wuxi Apptec
- 18.3.6.1. Overview
- 18.3.6.2. Product Portfolio
- 18.3.6.3. Sales Footprint
- 18.3.6.4. Strategy Overview
- 18.3.7. MPI Research
- 18.3.7.1. Overview
- 18.3.7.2. Product Portfolio
- 18.3.7.3. Sales Footprint
- 18.3.7.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology